Myeloablative_chemoradiotherapy_and_autologous_bone_marrow_infusions_for_treatment_of_neuroblastoma:_factors_influencing_engraftment._Bone_marrow_harvested_from_cancer_patients_for_autologous_bone_marrow_reinfusion_(ABMR)_after_myeloablative_treatment_may_be_injured,_in_both_its_proliferating_and_stromal_cell_pools,_by_either_previous_treatment_or_manipulation_at_the_time_of_harvest._We_have_examined_the_relative_effects_of_seven_covariates_on_hematologic_recovery_after_ABMR_in_children_with_neuroblastoma_(NBL)_using_univariate_and_step-up_analysis._We_measured_recovery_by_times_to_achieve_(1)_white_blood_cell_counts_greater_than_1,000/microL;_(2)_absolute_neutrophil_counts_greater_than_500/microL;_and_(3)_platelet_counts_greater_than_20,000/microL_without_transfusion._In_univariate_analysis,_recovery_was_significantly_associated_with_the_amount_of_prior_chemotherapy_and_the_interval_between_last_chemotherapy_and_marrow_harvest._Patient_sex,_the_number_of_granulocyte-macrophage_colonies_infused,_harvest-to-freeze_interval,_and_use_of_purging_were_marginally_associated._After_adjusting_for_potential_confounders_in_a_multivariate_model,_the_amounts_of_chemotherapy_and_granulocyte-macrophage_colonies_infused_were_independently_significant_predictors_of_time_to_total_white_blood_cell_count_recovery;_chemotherapy_courses_and_chemo-to-harvest_interval_were_predictors_of_neutrophil_count_recovery;_and_sex,_use_of_purging,_and_harvest-to-freeze_interval_were_marginal_predictors_of_platelet_recovery._The_speed_of_hematologic_recovery_after_ABMR_seems_to_depend_mainly_on_pre-existing_factors_and_marginally_on_manipulation_of_the_marrow_after_harvest._These_factors_may_affect_both_proliferating_and_stromal_cell_pools.